Julie Zhang, MBA

Julie ZHANG serves as VP, Oncology Regulatory Affairs Lead and Government Affairs Lead at Overland Pharmaceuticals.

Prior to Overland, Julie served as head of Rare disease, Hematology of Regulatory Affairs at Pfizer China and supported for registration strategy of the new products and license maintenance of approved products in these areas. Before joining Pfizer, she worked as RA Therapeutic Area lead at Sanofi China for Cardiovascular and Diabetes. Previously, she also worked at different positions in regulatory Affairs in some other multinational companies. She holds over 17 years of regulatory affairs experience covering multiple therapeutic areas including cardiovascular, metabolic disease, neuroscience, oncology, and rare disease.

Julie received her MBA from Université de Droit, d’économie et des Sciences d’Aix-Marseille and BS in Medicine from Beijing University of Traditional Chinese Medicine.